Call For Abstract

Scientific Program

13^th International Conference on Clinical Research & Clinical Trials, will be organized around the theme “Innovations and Transformations in Clinical Research”

EURO CLINICAL TRIALS 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in EURO CLINICAL TRIALS 2025

Submit your abstract to any of the mentioned tracks.

Track 1:Innovative Clinical Trial Design and Methodologies

This session focuses on the evolving landscape of clinical trial designs that enhance study efficiency and patient outcomes. It will cover adaptive trial designs, where modifications are made based on interim data analysis, and other novel designs such as basket, umbrella, and platform trials that allow for simultaneous investigation of multiple therapies or disease subtypes. Experts will discuss how these methodologies improve precision, reduce costs, and shorten timelines while addressing the operational challenges associated with their implementation. Real-world case studies demonstrating success and failure will provide practical insights.

Track 2:Decentralized and Virtual Clinical Trials

As technology reshapes the clinical trial paradigm, this session will explore the rise of decentralized clinical trials (DCTs), which use digital tools and remote monitoring to engage participants from their homes. Key topics include the logistical advantages of DCTs, such as broader patient reach and reduced site burden, alongside challenges like data privacy, regulatory hurdles, and maintaining participant engagement. The session will also discuss how to effectively utilize mobile health applications, telemedicine, and wearable devices to collect real-time data and ensure robust study endpoints.

Track 3:Digital Health Technologies and Artificial Intelligence in Clinical Research

This track will delve into the transformative role of digital health technologies and artificial intelligence (AI) in clinical research. It will cover how AI and machine learning are being utilized for patient recruitment, site selection, data management, and predictive modeling. Sessions will highlight real-world examples of AI-driven trials and the challenges of integrating these technologies, including data standardization, regulatory compliance, and algorithm transparency. The session aims to provide insights into how digital innovations can accelerate clinical research and improve data quality.

Track 4:Regulatory Compliance and Ethical Considerations in Clinical Trials

Navigating the complex global regulatory environment is crucial for successful clinical trials. This track will cover the regulatory frameworks across key regions such as the FDA in the USA, EMA in Europe, and PMDA in Japan. The session will explore best practices for maintaining compliance with these regulations, managing global trials, and understanding regional differences. Discussions will also focus on ethical considerations, including patient consent, privacy, and data protection in a digital age, and the challenges of conducting trials in vulnerable populations.

Track 5:Patient-Centric Approaches in Clinical Trials

This session will explore how to make clinical trials more patient-centric by incorporating patient perspectives into study design, execution, and analysis. Topics will include developing patient-friendly protocols, using digital tools to improve patient engagement, and understanding patient-reported outcomes. Experts will discuss the benefits of involving patients as partners in research, including improved recruitment and retention, and better data quality. Additionally, the session will cover strategies to enhance patient diversity and inclusion, addressing barriers to participation in underserved populations.

Track 6:Patient-Centric Approaches in Clinical Trials

Track 7:Real-World Evidence (RWE) and Real-World Data (RWD) in Clinical Research

This session will focus on the integration of real-world evidence (RWE) and real-world data (RWD) into clinical research. It will cover how RWE and RWD can complement traditional clinical trials by providing insights into treatment effectiveness, safety, and patient outcomes in routine clinical practice. Discussions will explore the regulatory landscape around RWE, data quality issues, and methodologies for incorporating RWE into study design and post-market surveillance. Case studies will illustrate how RWE can support faster and more cost-effective decision-making in drug development.

Track 8:Advances in Oncology Clinical Trials

Oncology trials are at the forefront of clinical research innovation. This track will focus on the unique challenges and advancements in designing and conducting oncology trials, such as the use of biomarker-driven studies, combination therapies, and novel endpoints like minimal residual disease. It will cover strategies to improve patient recruitment, address regulatory challenges, and enhance collaboration among stakeholders. The session will also explore the ethical considerations in oncology trials, such as balancing the need for innovative therapies with patient safety.

Track 9:Pediatric and Geriatric Clinical Trials

This track will address the unique considerations for conducting clinical trials in pediatric and geriatric populations. It will explore challenges such as ethical concerns, age-specific pharmacokinetics, and comorbidities, as well as regulatory requirements that differ from adult trials. Discussions will include innovative approaches to study design, patient recruitment, and data collection that account for the physiological and developmental differences in these populations. The session will also cover strategies to ensure adequate representation and meaningful outcomes.

Track 10:Innovations in Data Management and Statistical Analysis

This session will highlight advancements in data management and statistical analysis techniques that are transforming clinical research. Topics include big data analytics, data integration from multiple sources, and the use of real-time data monitoring to enhance study quality and efficiency. Speakers will discuss the latest statistical methodologies, such as Bayesian modeling and machine learning algorithms, for designing more robust trials and interpreting complex datasets. The session will also cover the importance of data standardization and compliance with regulatory guidelines.

Track 11:Patient Recruitment, Retention, and Engagement Strategies

Patient recruitment and retention remain critical challenges in clinical trials. This track will cover innovative strategies to improve patient engagement, such as using digital tools, social media, and community outreach. Discussions will focus on overcoming barriers to participation, including logistical, financial, and cultural challenges, and ensuring diverse patient representation. Case studies will provide insights into successful recruitment campaigns, while interactive sessions will explore how to improve patient experience and reduce dropout rates.

Track 12:Role of CROs (Contract Research Organizations) in Clinical Trials

This session will explore the evolving role of Contract Research Organizations (CROs) in the clinical trial landscape. It will cover how CROs are partnering with sponsors to manage complex global trials, navigate regulatory challenges, and ensure data integrity. Discussions will include strategies for selecting the right CRO partner, managing relationships, and optimizing collaboration. The session will also explore the impact of emerging trends, such as decentralized trials and digital tools, on the role of CROs.

Track 13:Globalization of Clinical Trials: Opportunities and Challenges

This track will focus on the globalization of clinical trials, highlighting both opportunities and challenges. Topics will include navigating diverse regulatory landscapes, understanding cultural differences, and managing logistics in multi-regional trials. Discussions will explore strategies to enhance global collaboration, ensure patient safety, and maintain data quality across borders. The session will also address ethical considerations, such as ensuring informed consent and protecting vulnerable populations in international trials.

Track 14:Drug Safety, Pharmacovigilance, and Risk Management

This session will cover the importance of drug safety, pharmacovigilance, and risk management throughout the clinical trial process. Topics will include strategies for detecting, assessing, and reporting adverse events, as well as best practices for risk communication and management. Discussions will explore the role of digital tools in improving safety monitoring and the impact of regulatory requirements on pharmacovigilance practices. Case studies will provide insights into effective risk management strategies.

Track 15:Biomarkers and Personalized Medicine in Clinical Trials

This track will delve into the role of biomarkers in advancing personalized medicine and improving clinical trial outcomes. Topics will include the identification and validation of predictive and prognostic biomarkers, the integration of biomarkers into clinical trial design, and the regulatory challenges associated with biomarker-driven studies. Discussions will highlight real-world examples of successful biomarker-guided trials and explore the future of personalized medicine in clinical research.

Track 16:Post-Market Surveillance and Phase IV Trials

This session will focus on the role of post-market surveillance and Phase IV trials in ensuring long-term drug safety and efficacy. Topics will include designing and conducting Phase IV studies, monitoring real-world drug use, and managing adverse events. Discussions will explore the use of real-world data and digital tools to enhance post-market surveillance and meet regulatory requirements. Case studies will provide insights into successful Phase IV trials and highlight best practices for maintaining patient safety.